Global new drug development (Record no. 9327)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02293nam a22003017a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305192615.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220906b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-1-118-41488-0 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | DLC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RS420 |
| Classification number | QV 745] |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Edition information | 23 |
| Classification number | 615.1′9 ROS |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Jan A. Rosier |
| 9 (RLIN) | 44000 |
| 245 ## - TITLE STATEMENT | |
| Title | Global new drug development |
| Remainder of title | an introduction |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Oxford: |
| Name of publisher, distributor, etc. | Wiley Backwell, |
| Date of publication, distribution, etc. | c2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 427 pages |
| Other physical details | Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The development of new drugs is very complex, costly and risky. Its success is highly dependent on an intense collaboration and interaction between many departments within the drug development organization, external investigators and service providers, in constant dialogue with regulatory authorities, payers, academic experts, clinicians and patient organizations. Within the different phases of the drug life cycle, drug development is by far the most crucial part for the initial and continued success of a drug on the market.<br/><br/>This book offers an introduction to the field of drug development with a clear overview of the different processes that lead to a successful new medicine and of the regulatory pathways that are used to launch a new drug that are both safe and efficacious.<br/><br/>"This is the most comprehensive and detailed book on drug development I have ever read and I feel that it is likely to become a staple of drug development courses, such as those taught at Masters Level in my own University.... I think in the light of increasing integration of company and academic approaches to drug development both sides can read this book... (and, therefore)... this book could not be more timely."<br/>—Professor Mike Coleman, University of Aston, UK ( from his review of the final manuscript) |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Drug Industry–organization & administration. |
| 9 (RLIN) | 44001 |
| General subdivision | Drug Discovery. |
| 9 (RLIN) | 44002 |
| General subdivision | Science › Life Sciences › Biophysics |
| 9 (RLIN) | 26929 |
| General subdivision | Medical / Pharmacy |
| 9 (RLIN) | 27229 |
| General subdivision | Science / Life Sciences / Biophysics |
| 9 (RLIN) | 26928 |
| General subdivision | Technology & Engineering / Chemical & Biochemical |
| 9 (RLIN) | 28700 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 44003 |
| 9 (RLIN) | 44004 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | BOOKS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 09/06/2022 | 615.1′9 ROS | EBS13388 | 09/06/2022 | 09/06/2022 | E-BOOKS |